Kai Zhao

Dr. Kai Zhao


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
CXChun-Lin Xiao
Chun-Lin Xiao
WYWen-Chao Yin
Wen-Chao Yin
YZYan-Chun Zhong
Yan-Chun Zhong
JLJia-Quan Luo
Jia-Quan Luo
LLLu-Lin Liu
Lu-Lin Liu
KZKai Zhao
Kai Zhao
Spinal cord injury (SCI) is a severely disabling central nervous system injury with complex pathological mechanisms that leads to sensory and motor dysfunction. The current treatment for SCI is aimed at symptomatic symptom relief rather than the pathological causes. Several studies have reported that signaling pathways play a key role in SCI pathological processes and neuronal recovery mechanisms. The PI3K/Akt signaling pathway is an important pathway closely related to the pathological process of SCI, and activation of this pathway can delay the inflammatory response, prevent glial scar formation, and promote neurological function recovery. Activation of this pathway can promote the recovery of neurological function after SCI by reducing cell apoptosis. Based on the role of the PI3K/Akt pathway in SCI, it may be a potential therapeutic target. This review highlights the role of activating or inhibiting the PI3K/Akt signaling pathway in SCI-induced inflammatory response, apoptosis, autophagy, and glial scar formation. We also summarize the latest evidence on treating SCI by targeting the PI3K/Akt pathway, discuss the shortcomings and deficiencies of PI3K/Akt research in the field of SCI, and identify potential challenges in developing these clinical therapeutic SCI strategies, and provide appropriate solutions.

2 August 2024 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
CXChunlin Xiao
Chunlin Xiao
HLHong-Tong Lai
Hong-Tong Lai
JZJiang-Jun Zhou
Jiang-Jun Zhou
WLWu-Yang Liu
Wu-Yang Liu
MZMin Zhao
Min Zhao
KZKai Zhao
Kai Zhao

24 June 2025 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
YXYu Xing
Yu Xing
YXYuan-Zhang Xiao
Yuan-Zhang Xiao
MZMin Zhao
Min Zhao
JZJiang-Jun Zhou
Jiang-Jun Zhou
KZKai Zhao
Kai Zhao
CXChunlin Xiao
Chunlin Xiao
Spinal cord ischemia/reperfusion injury (SCIRI) is a serious disease that leads to the loss of sensory and motor functions and is a common complication after spinal cord injury, spinal cord degeneration or thoracic and abdominal aortic surgery. At present, the spinal cord is mainly protected from ischemic injury through treatment strategies such as hypothermia, surgery and drug assistance, but these intervention measures cannot effectively improve these conditions. SCIRI is a complex process that leads to cell damage and death. Among them, oxidative stress is an important pathological event of ischemia/reperfusion injury. Oxidative stress can initiate multiple inflammatory and apoptotic pathways, triggering a series of destructive events such as inflammatory responses and cell death, further deteriorating the microenvironment at the injured site, and leading to neurological dysfunction. Based on the important role of oxidative stress in SCIRI, we believe that targeted inhibition of oxidative stress responses can effectively reduce secondary injuries caused by trauma, which has a certain positive effect on the rehabilitation and prognosis of patients with SCIRI. This review systematically expounds the spatiotemporal dynamic characteristics of oxidative stress during the SCIRI process and its molecular regulatory network, with a focus on analyzing the multivariate generation mechanism of ROS. To deeply explore the regulatory effects of ROS on pathological processes such as neuronal death, inflammatory response and blood-spinal barrier disruption under SCIRI conditions, as well as its interaction patterns with signaling pathways. In order to form a systematic treatment for SCIRI caused by oxidative stress and promote the recovery of neurological function after injury. This review is helpful for us to understand the effect of oxidative stress on SCIRI and provides a theoretical basis for the treatment of SCIRI based on oxidative stress.

1 July 2022 in Bone & Joint Research
Verified
Journal Article
Open access
CTChen Tu
Chen Tu
SLSiqi Lai
Siqi Lai
ZHZhiwei Huang
Zhiwei Huang
GCGuixing Cai
Guixing Cai
KZKai Zhao
Kai Zhao
ZZZhao Ming Zhong
Zhao Ming Zhong
Aims: Gap junction intercellular communication (GJIC) in osteocytes is impaired by oxidative stress, which is associated with age-related bone loss. Ageing is accompanied by the accumulation of advanced oxidation protein products (AOPPs). However, it is still unknown whether AOPP accumulation is involved in the impairment of osteocytes’ GJIC. This study aims to investigate the effect of AOPP accumulation on osteocytes’ GJIC in aged male mice and its mechanism.Methods: Changes in AOPP levels, expression of connexin43 (Cx43), osteocyte network, and bone mass were detected in 18-month-old and three-month-old male mice. Cx43 expression, GJIC function, mitochondria membrane potential, reactive oxygen species (ROS) levels, and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation were detected in murine osteocyte-like cells (MLOY4 cells) treated with AOPPs. The Cx43 expression, osteocyte network, bone mass, and mechanical properties were detected in three-month-old mice treated with AOPPs for 12 weeks.Results: The AOPP levels were increased in aged mice and correlated with degeneration of osteocyte network, loss of bone mass, and decreased Cx43 expression. AOPP intervention induced NADPH oxidase activation and mitochondrial dysfunction, triggered ROS generation, reduced Cx43 expression, and ultimately impaired osteocytes’ GJIC, which were ameliorated by NADPH oxidase inhibitor apocynin, mitochondria-targeted superoxide dismutase mimetic (mito-TEMPO), and ROS scavenger N-acetyl cysteine. Chronic AOPP loading accelerated the degradation of osteocyte networks and decreased Cx43 expression, resulting in deterioration of bone mass and mechanical properties in vivo.Conclusion: Our study suggests that AOPP accumulation contributes to age-related impairment of GJIC in osteocytes of male mice, which may be part of the pathogenic mechanism responsible for bone loss during ageing. Cite this article: Bone Joint Res 2022;11(7):413–425.

20 November 2025 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
YXYu Xing
Yu Xing
YXYuan-Zhang Xiao
Yuan-Zhang Xiao
MZMin Zhao
Min Zhao
JZJiang-Jun Zhou
Jiang-Jun Zhou
KZKai Zhao
Kai Zhao
CXChunlin Xiao
Chunlin Xiao
• Please read through all the templates before choosing • Pick the most relevant text template(s) from the following page and delete all others. • Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • Submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated. , Yuan-Zhang Xiao 1,2 † , Min Zhao 3 , Jiang-Jun Zhou 4 , Kai Zhao 1,2* and Chun-Lin Xiao 1,2* )In the published article, there was a mistake in the designation of co-first authors. The author List was erroneously given as [Yu Xing 1,2 , Yuan-Zhang Xiao 1,2 † , Min Zhao 3 , Jiang-Jun Zhou 4 , Kai Zhao 1,2* † and Chun-Lin Xiao 1,2* ]. The dagger symbol " †" should be placed next to Yu Xing's name, rather than Kai Zhao's. The correct author list is [Yu Xing 1,2 † , Yuan-Zhang Xiao 1,2 † , Min Zhao 3 , Jiang-Jun Zhou 4 , Kai Zhao 1,2* and Chun-Lin Xiao 1,2* ].here, please contact the journal's editorial office.

12 October 2026 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
XWXinping Wang
Xinping Wang
YCYingchao Cai
Yingchao Cai
RLRenwei Liu
Renwei Liu
YXYuanzhang Xiao
Yuanzhang Xiao
WLWuyang Liu
Wuyang Liu
KZKai Zhao
Kai Zhao